Related Experiment Video
Updated: Sep 19, 2025

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
Low awareness of lipid disorders amongst individuals despite their high prevalence
Aimee Walsh1, Ruth Agar1, Greg Offiah1
1Advanced Lipid Management and Research (ALMAR) Centre, Tallaght University Hospital, Dublin, Ireland.
Background:
Atherosclerotic cardiovascular disease (ASCVD) usually goes undetected until complications develop. Knowledge and awareness of cardiovascular risk factors, particularly lipid disorders, lead to earlier disease detection and risk factor intervention.
Aim:
We sought to assess the awareness of lipid disorders in a population randomly screened for lipid abnormalities.
Methods:
As part of a national awareness campaign, 360 individuals underwent lipid screening and completed a questionnaire regarding their awareness of cardiovascular risk factors.
Results:
We identified 240 (66%) individuals with a lipid disorder. Lipid disorders were unrelated to gender but increased sharply from 39% in those under 40 years of age to (71%) in those between 40 and 54 years and (75%) in those older than 55 years. They were more prevalent in those reporting diabetes (78%), hypertension (88%) and hypercholesterolaemia (90%) but not in smokers 62% versus non-smokers 68%. Awareness of abnormal lipids was present in only 34% of individuals overall but was higher in those with diabetes (70%) hypertension (64%) or in those with two or more risk factors (50%). Awareness of lipid disorders increased with age, being extremely low (8%) in those under 40 years of age and increasing to (28%), (45%) and (54%) in those aged 40 to 54 years, 55 to 70 years and older than 70 years, respectively. The biggest gap between the presence and awareness of lipid disorders occurred in the 40 to 54 year age group. There were significant correlations between the awareness of lipid disorders and the awareness of hypertension r = 0.27, p < 0.01 or diabetes r = 0.14, p < 0.05 but not of smoking r = - 0.04 or family history of ASCVD r = 0.11.
Conclusions:
Given the importance of early detection and intervention to reduce cardiovascular disease risk factors, public education and increased screening are advisable, especially for lipid disorders in the youngerage groups.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipids: Dietary Sources and Requirements
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Atherosclerosis III: Management